Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-23 · accession 0000950170-23-023939 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-24 | 2023-05-23 | CGEM | AHMED NADIM | Pres, CEO, Dir | S - Sale | $9.15 | -707 | 116.6K | -0.6% | -$6,469 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-23 | S | D | 707 | $9.15 | 116,581 | D | — | — | (F1) Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. |